Motif Bio PLC Investor presentation
24 Maggio 2016 - 8:02AM
RNS Non-Regulatory
TIDMMTFB
Motif Bio PLC
24 May 2016
24 May 2016
Motif Bio plc
("Motif" or the "Company")
Investor Presentation
Motif Bio plc (AIM: MTFB) the clinical stage biopharmaceutical
company specialising in developing novel antibiotics, announces it
will be holding a presentation for investors on Tuesday 21 June
2016.
The event will be held at the Black Bar, upstairs at Rocket Bar,
6 Adams Court, Old Broad Street, London, EC2N 1DX from 4.45pm for a
5.00pm start.
A presentation will be given by management and will cover an
overview of the Company, where it is currently positioned and its
plans for the future. This will be followed by an opportunity to
network over drinks and canapés.
To register for the event, please contact
motifbio@walbrookpr.com or call the Walbrook PR team below.
For further information please contact:
Walbrook PR Ltd. (FINANCIAL +44 (0)20 7933 8780 or motifbio@walbrookpr.com
PR & IR) Mob: +44 (0)7584 391 303
Lianne Cawthorne
Notes to Editors:
Motif Bio is a clinical-stage biopharmaceutical company,
specialising in the development of novel antibiotics that are
designed to be effective against serious and life-threatening
infections caused by multi-drug resistant bacteria. Our lead
product candidate, iclaprim, is being developed for the treatment
of the most common and serious bacterial infections such as acute
bacterial skin and skin structure infections (ABSSSI) and hospital
acquired bacterial pneumonia (HABP), including those caused by
resistant strains such as MRSA (methicillin-resistant
Staphylococcus aureus). Two Phase III ABSSSI clinical trials are on
track to be completed in 2017 and if approved, iclaprim could be
ready for commercialization in 2018. The Company is in discussions
with pharmaceutical companies and universities to build a pipeline
of innovative antibiotics targeting Gram-positive and Gram-negative
bacteria. For additional information about Motif Bio please visit
www.motifbio.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRALLFEREFIVFIR
(END) Dow Jones Newswires
May 24, 2016 02:02 ET (06:02 GMT)
Grafico Azioni Motif Bio (LSE:MTFB)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Motif Bio (LSE:MTFB)
Storico
Da Lug 2023 a Lug 2024
Notizie in Tempo Reale relative a Motif Bio Plc (Borsa di Londra): 0 articoli recenti
Più Motif Bio Articoli Notizie